On 2025-08-07, NextCure, Inc. (NXTC) announced earnings per share of $-11.29 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-4.62.
The next expected annoucement date for quarterly earnings is 2025-11-06, with an average estimated earnings per share of $-4.06 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-07 | 2025-06-30 | $-4.62 | $-11.29 |
| 2025-05-01 | 2025-03-31 | $-4.80 | $-4.68 |
| 2025-03-06 | 2024-12-31 | $-4.08 | $-4.92 |
| 2024-11-07 | 2024-09-30 | $-4.20 | $-4.92 |
| 2024-08-01 | 2024-06-30 | $-4.32 | $-6.60 |
| 2024-05-02 | 2024-03-31 | $-5.40 | $-7.32 |
| 2024-03-21 | 2023-12-31 | $-6.48 | $-6.24 |
| 2023-11-02 | 2023-09-30 | $-7.68 | $-6.12 |
| 2023-08-03 | 2023-06-30 | $-7.20 | $-7.68 |
| 2023-05-04 | 2023-03-31 | $-7.68 | $-6.96 |
| 2023-03-02 | 2022-12-31 | $-7.80 | $-7.44 |
| 2022-11-03 | 2022-09-30 | $-7.20 | $-8.16 |
| 2022-08-04 | 2022-06-30 | $-8.76 | $-7.80 |
| 2022-05-05 | 2022-03-31 | $-8.16 | $-8.88 |
| 2022-03-03 | 2021-12-31 | $-8.04 | $-7.32 |
| 2021-11-04 | 2021-09-30 | $-8.04 | $-7.80 |
| 2021-08-05 | 2021-06-30 | $-7.20 | $-7.80 |
| 2021-05-06 | 2021-03-31 | $-6.84 | $-7.20 |
| 2021-03-04 | 2020-12-31 | $-6.96 | $-6.72 |
| 2020-11-05 | 2020-09-30 | $-6.72 | $-7.08 |
| 2020-08-06 | 2020-06-30 | $-5.40 | $-6.36 |
| 2020-05-07 | 2020-03-31 | $-6.96 | $3.96 |
| 2020-03-12 | 2019-12-31 | $-3.96 | $-4.08 |
| 2019-11-12 | 2019-09-30 | $-4.20 | $-4.44 |
| 2019-08-12 | 2019-06-30 | $-5.64 | $-7.32 |
| 2019-06-10 | 2019-03-31 | $-6.36 | $-53.54 |